The summary is not ready yet
The Layman's summary is not ready yet
The blog article is not ready yet
BackgroundSevere fatigue is common in diffuse glioma patients and can persist after tumor treatment. Fatigue-tailored blended cognitive behavioral therapy (bCBT) has been shown to reduce severe fatigue in glioma patients. This study aimed to identify barriers and facilitators to implementing bCBT for severe fatigue in glioma care and to develop implementation strategies tailored to the neuro-oncology context. MethodsA qualitative study was conducted among healthcare professionals involved in glioma care, including neurologists, nurse practitioners, and (neuro)psychologists. Semi-structured interviews were conducted with a topic list guided by the Consolidated Framework for Implementation Research. Data were analyzed using a combined deductive and inductive approach. Implementation strategies were developed by integrating identified barriers and facilitators, participant suggestions, and research team expertise. ResultsTwenty-six healthcare professionals from several Dutch neuro-oncological centers participated in this study. Key themes of implementation included the perceived need for fatigue treatment with bCBT, referral to psychological care, knowledge on patient eligibility for bCBT, awareness of fatigue and bCBT, confidence in its evidence, capacity constraints, digital platform access and financial responsibility. Implementation strategies were tailored to identified barriers across three phases: identifying fatigue, referring diffuse glioma patients and treating severe fatigue with bCBT. ConclusionsImplementation of bCBT for severe fatigue in glioma care requires more than evidence of effectiveness. Successful integration into routine hospital care will depend on timely fatigue identification, clear referral responsibilities, appropriate patient selection, trained professionals and alignment with local organizational and financial conditions. Center-specific implementation strategies may facilitate integration of bCBT into neuro-oncology care. Key pointsO_LIAwareness of fatigue and bCBT together with eligibility guidelines for bCBT are key for adoption. C_LIO_LIReferral pathways, financial responsibility and limited capacity may hinder implementation. C_LIO_LIIntegration into routine hospital care will likely require center-specific strategies. C_LI Importance of studyBlended cognitive behavioral therapy (bCBT) is effective in reducing severe fatigue in patients with diffuse glioma. This qualitative study was conducted as a pre-implementation step from the perspectives of neurologists, nurse practitioners, and (neuro)psychologists to support adoption of bCBT in neuro-oncology care. Barriers and facilitators identified were related to the need for fatigue reduction, awareness of fatigue and bCBT, confidence in its evidence, patient suitability, referral pathways, psychological care capacity, and financial responsibility. Implementation needs differed across centers according to existing fatigue assessment practices, care pathways, organizational structures, and available digital platforms. These findings indicate that implementation is unlikely to be achieved by a single uniform strategy. Instead, center-specific approaches aligned with existing workflows are needed. Lay summaryFatigue is the most common and burdensome symptom for people with brain tumors (gliomas). A cognitive-behavioral treatment combining online and in-person therapy, has shown to help, but hospitals have not widely adopted it. We interviewed neurologists, nurse practitioners and psychologists to understand what helps or hinders its use in hospital care, then developed strategies to address the challenges identified. Healthcare professionals recognized a clear need for fatigue reduction, but uptake in routine care may be hindered by limited awareness of fatigue and the treatment, staffing and resource constraints and unclear financial responsibility. Different hospitals will likely need tailored approaches for successful adoption.